BiosimilarR & D, Regulatory & PolicySamsung Bioepis receives FDA approval for first Ranibizumab (Lucentis®) BiosimilarSeptember 21, 20210
Patented Drugs & VaccinesR & D, Regulatory & PolicySamsung’s Byooviz receives EMA approvalSeptember 1, 20210
DealsR & D, Regulatory & PolicyJazz Pharma’s Xywav Gets FDA Approval for Idiopathic Hypersomnia in AdultsAugust 25, 20210
DealsR & D, Regulatory & PolicyLumen Bioscience teams with Google to Apply ML to Biologics ManufacturingAugust 17, 20210
DealsR & D, Regulatory & PolicySanofi to Acquire Translate Bio for USD 3.2 Bn to Expand m-RNA Platform ProductsAugust 10, 20210
BiosimilarR & D, Regulatory & PolicySemglee becomes first biosimilar to gain interchangeability designation –A critical milestoneJuly 29, 20210
Patented Drugs & VaccinesR & D, Regulatory & PolicyUS FDA approves fexinidazole as the first all-oral treatment for sleeping sicknessJuly 29, 20210
DealsR & D, Regulatory & PolicyBayer’s Kerendia receives USFDA approval for kidney and heart disease in Type 2 diabetes patientsJuly 16, 20210
Patented Drugs & VaccinesR & D, Regulatory & PolicyActemera receives FDA EUA to treat hospitalized COVID-19 patientsJuly 8, 20210
DealsR & D, Regulatory & PolicyMorphoSys Buys Constellation and Enters Partnership with Royalty PharmaJune 17, 20210
